As a driver of EMT, ZEB1 downregulates canonical epithelial genes (e.g., E-cadherin, occludin) and upregulates mesenchymal markers (e.g., vimentin, fibronectin) in different types of carcinomas (20, 48, 49). This evidence concerns the gene FN1 and carcinoma.